Hydrogen Gas Inhalation Therapy Shows Promise in Protecting Bone Marrow During Cancer Radiation Treatment: Observational Study Finds
In this study, researchers compared the effects of two different therapies on bone marrow damage in cancer patients undergoing intensity-modulated radiation therapy (IMRT). The first therapy was mild hyperbaric oxygen therapy, which is a commonly used treatment to help increase oxygen flow to damaged tissues. The second therapy was inhalation of 5% hydrogen gas, which has been shown to have antioxidant properties that can help protect cells from damage.
The study was conducted as a retrospective observational study, meaning that the researchers did not actively intervene in the patients' treatments but instead analyzed data from medical records. Patients were divided into two groups: a control group that received hyperbaric oxygen therapy after each IMRT session, and an experimental group that received hydrogen gas inhalation therapy.
To assess the effectiveness of the therapies, the researchers analyzed the patients' peripheral blood before and after IMRT treatment to evaluate bone marrow damage. They measured changes in white blood cells, red blood cells, platelets, hemoglobin, and hematocrit, and expressed the data as a ratio of post-treatment to pre-treatment levels.
The results showed that both therapies reduced white blood cells and platelets, but hydrogen gas inhalation therapy was more effective at mitigating the effects of radiation on these cells. This suggests that hydrogen gas inhalation therapy may be a more effective way to protect bone marrow during radiation therapy.
Overall, the study's findings suggest that hydrogen gas inhalation therapy could be a beneficial adjunct therapy for cancer patients undergoing radiation treatment. It is important to note that this was an observational study and more research is needed to confirm these results, but the potential benefits of hydrogen gas inhalation therapy are certainly worth exploring further.
原文來自：
コメント